Evidence map›Paper›PMID 22531957›Full record

ArticleInternational urogynecology journal2012

The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: a retrospective cohort study.

P Diamond, S Hassonah, M Alarab, D Lovatsis, H P Drutz

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in International urogynecology journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04693897 (To Explore the Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and Develop Its Urinary Biomarker), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04693897 unknown statusnot on this mapstarted 2021, after this paper: background citation

To Explore the Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and Develop Its Urinary Biomarker

Typeobservational_patient_registrySponsorChang Gung Memorial HospitalRan2021 to 2022Enrolled400ConditionsOveractive Bladder Syndrome, Detrusor OveractivityArmsMirabegron 50 MG, Solifenacin Succinate 5 MG
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Detrusor Overactivity and Urodynamics.Neurourology and urodynamics · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

P DiamondDivision of Urogynecology and Reconstructive Pelvic Surgery, Mount Sinai Hospital, 700 University Avenue, Rm 801, Toronto, ON, Canada M5G 1Z5. diamond.phaedra@gmail.com
S Hassonah
M Alarab
D Lovatsis
H P Drutz

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisOveractive bladder (OAB) is a symptom-based condition consisting of urgency, with or without incontinence, usually with frequency and nocturia. There are many potential causes of OAB, yet many patients are prescribed anticholinergic medications empirically. This study aimed to determine what proportion of patients presenting for urogynecologic assessment with symptoms of OAB had urodynamic detrusor overactivity (DO).

methodsRetrospective chart review was performed for 220 consecutive patient referrals. Demographic data, physical exam information, and urodynamic results were collected. The t test and Fisher's exact test were used for statistical analyses.

resultsThe prevalence of DO was 11.8 % in this population. Urogenital atrophy and incomplete emptying were more common. Patients with DO were older and more often menopausal than those without DO. Significant prolapse was a common finding amongst patients with OAB symptoms.

conclusionsPatients with symptoms of OAB should undergo pelvic examination and assessment of post-void residuals before being initiated on anticholinergic medication.

Indexed as

AgedCholinergic AntagonistsCohort StudiesFemaleGynecological ExaminationHumansMiddle AgedMuscle, SmoothPrevalenceRetrospective StudiesUrinary Bladder, OveractiveUrodynamicsCholinergic Antagonists

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.